Please assess the completion status of the following clinical trial:

Trial Title: Fluoxetine for Anxious Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~-~Patients must have:~Generalized anxiety disorder.~Exclusion Criteria:~-~Excluded:~Patients with current major depression, as well as patients with panic and obsessive-compulsive disorder.~-~Excluded:~Current substance abuse.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 17 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).